Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that was approved by the FDA in 2010 for treating excess abdominal fat in HIV-positive patients with lipodystrophy. Unlike many peptides in this category, Tesamorelin has undergone rigorous clinical testing and carries formal regulatory approval for a specific medical indication. Studies have shown it effectively reduces visceral adipose tissue while increasing lean mass. Though its approved use is narrow, some clinicians prescribe it off-label for other conditions involving growth hormone deficiency or age-related metabolic changes.
Tesamorelin
Price range: £90.00 through £130.00
| Amount | 5mg, 10mg |
|---|
Related products
-
BPC-157
Price range: £40.00 through £50.00Select options This product has multiple variants. The options may be chosen on the product page -
MOTS-c
Price range: £60.00 through £90.00Select options This product has multiple variants. The options may be chosen on the product page -
Retatrutide
Price range: £60.00 through £80.00Select options This product has multiple variants. The options may be chosen on the product page -
GHK-Cu
Price range: £40.00 through £50.00Select options This product has multiple variants. The options may be chosen on the product page